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Demystifying	wound	infection:	
identification	and	management
Wound infection can be costly both in terms of 
delayed healing and the 
detrimental effect on the 
patient’s quality of life. High 
Quality Care for All 
(Department of Health (DH), 
2008) envisaged putting 
quality at the heart of 
everything the NHS does, 
therefore the ability to 
recognize and treat wound 
infections is an essential skill 
for each and every 
practitioner dealing with 
wound management.
Wound infection is a 
common surgical 
complication. Surgical site 
infections are associated with 
considerable morbidity and it 
has been reported that over 
one third of post-operative 
deaths are related, at least in 
part, to surgical site infections 
(Astagneau, 2001). 
Surgical site infections 
account for 15% of all health-
care-associated infections 
(Health Protection Agency 
(HPA), 2009). They are also 
associated with considerable 
morbidity and estimated to  
at least double the length of 
hospital stay, thereby 
increasing the costs of health 
care (HPA, 2009).
Additional costs 
attributable to surgical site 
infections of between £814 
and £6626 have been 
reported depending on the 
type of surgery and the 
severity of the infection 
(National Collaborating 
Centre for Women’s and 
Children’s Health 
(NCC-WCH), 2008). 
The main additional costs 
are related to repeat 
operation, extra nursing care 
and interventions, and drug 
treatment costs. The indirect 
costs, owing to loss of 
productivity, patient 
dissatisfaction and litigation, 
and reduced quality of life, 
have been studied less 
extensively (NCC-WCH, 
2008).
The HPA (2009) reported 
that during 2008, 1191 
surgical site infections were 
detected from 94 750 surgical 
procedures in 251 hospitals 
(including NHS and private). 
About 30% of the surgical 
site infections required 
readmssion.
Wound	infection
Wound infection occurs as  
a result of a dynamic 
interaction between the host 
and the pathogen (White, 
2009). All wounds are 
contaminated with a variety 
of microorganisms.
Contamination refers to the 
presence of organisms on the 
surface of the wound (Stotts, 
2004). Often these microbes 
are harmless and are naturally 
found on the surface of the 
skin; these are known as skin 
flora. Intact skin forms a 
physical barrier against 
microbes and many other 
bacteria but once this defence 
mechanism is broken, with 
the creation of a wound, 
bacteria are provided with a 
perfect environment to grow 
and multiply, i.e. a warm, 
moist surface with plenty of 
nutrients available.  
Bacterial load or burden is 
an important concept in the 
understanding of wound 
infection. Kingsley (2001) 
described the notion of a 
continuum in the development 
of wound infection from 
sterility to infection. Infection 
occurs when the sum of the 
bacterial burden is greater 
than the host’s immune 
defences, leading to a 
systematic immunological 
reaction. 
There are four states in the 
development of microbial 
infection (Table 1): 
 ➤ Contamination
 ➤ Colonization
 ➤ Critical colonization 
 ➤ Wound infection.
Bacteria are present in all 
wounds. Where the number of 
bacteria in a wound is low 
(contamination), there is no 
impairment of wound healing. 
As the number of bacteria in 
the wound rises, infection 
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Wound infection delays healing and impairs quality of life. Leanne Cook and Karen Ousey discuss the 
recognition and treatment of wound infections, which are essential skills for practice nurses
Table	1.	The	four	microbial	states	of	the	wound	
infection	continuum	
Term Definition
Contamination Bacteria are present on the surface of the wound but 
do not multiply and do not cause an immune 
response
Colonization The presence of multiplying bacteria in a wound is 
balanced, or is kept in check by the patient’s immune 
system. The bacteria do not interfere with wound 
healing and do not damage wound tissue or trigger an 
immune response. A normally healing wound is 
colonized with bacteria
Critical colonization The point at which the patient’s immune response 
can no longer control the colonizing bacteria in the 
wound, resulting in delayed wound healing
Infection The presence of multiplying bacteria which 
overwhelm the patient’s immune system, disrupting 
healing and damaging wound tissue and the host’s 
immune response
From: Patel, 2007; Wounds UK, 2010.
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and also helps with the 
management of the wound. 
The HPA (2008: 18) defines 
three types of surgical site 
infection:
 ➤ Superficial incisional 
infection
 ➤ Deep incisional infection
 ➤ Organ/space infection.
Superficial	incisional	
infection
A superficial incisional 
infection is one that occurs 
within 30 days of surgery and 
involves only the skin or 
subcutaneous tissue of the 
incision. Criteria include 
purulent draining, positive 
culture from aspirated fluid or 
wound swab, evidence of pain, 
tenderness, local swelling and/
or heat and redness.
Deep	incisional	infection
A deep incisional infection is 
defined as a surgical site 
infection involving the deep 
tissues (i.e. fascial and muscle 
layers) that occurs within 
30 days of surgery if no 
implant is in place, or within 
1 year if an implant is in place 
and the infection appears to 
be related to the surgical 
procedure. Diagnostic criteria 
include purulent draining 
from the deep incisional space 
but not from the organ/space, 
formation of abscess in or 
around deep incision, positive 
culture from aspirate or 
wound swab, deep incision 
that spontaneously dehisced 
or one that has been 
deliberately opened by a 
surgeon (Figure 2). 
Organ/space	infection
Organ/space infection is 
defined as a surgical site 
infection involving any part of 
the anatomy other than the 
incision. It occurs within 
30 days of surgery if no 
implant is in place, or within 
1 year if an implant is in place 
and the infection appears to 
be related to the surgical 
procedure. Organ/space 
infection is associated with 
the surgical procedure and in 
addition has one of the 
following: purulent discharge 
into a drain placed into an 
organ/space, positive culture 
from aspirated fluid or tissue 
sample, or abscess formation.
The HPA (2009) provides 
full guidance to surgical site 
infection and classifcation.
Diagnosing	infection
The diagnosis of infection is 
primarily a clinical skill based 
on a complete and accurate 
assessment of the wound and 
the patient in combination 
with laboratory tests. 
Most practitioners would 
feel comfortable identifying 
frank infection in a wound 
but find it more difficult to 
distinguish between those 
wounds that are colonized 
and those that are critically 
colonized. Depending on the 
host response to the bacteria 
even relatively low levels of 
bacterial burden can impair 
wound healing (Stephen-
Hayes and Toner, 2007). 
It is essential that the 
correct diagnosis of wound 
infection is made to ensure 
effective management. Several 
classical signs and symptoms 
accompany wound infection 
but not all wounds will 
exhibit all these signs at any 
one time (Table 2). Classical 
signs include pain, redness 
(erythema), heat, oedema and 
purulent exudate.
Cutting et al (2005) 
becomes more likely. At the 
state of critical colonization, 
the wound’s bacterial burden 
reaches an imbalance, 
provoking infection if the 
bacterial burden is not 
effectively managed (Kingsley, 
2001) (Figure 1). 
The pathogens most 
commonly associated with 
wound infections in the UK 
are Staphylococcus aureus, 
Streptococcus species, 
Pseudomonas aeruginosa and 
anaerobes (Cooper, 2005).
Infection can occur on 
acute wounds such as surgical 
wounds (surgical site infections) 
and on chronic wounds such 
as pressure ulcers, diabetic 
foot ulcer and leg ulcers, 
which are more likely to be 
colonized with bacteria due to 
the nature of the open wound 
and tissue type (Vazquez-
Boland et al, 2006).
 
Classification	of	
surgical	site	infections
Surgical site infections 
develop within 30 days of an 
operation or within 1 year if 
an implant was placed within 
the wound and the infection 
appears to be related to the 
surgery.
The ability to classify 
surgical site infections by 
severity is important when 
reporting and auditing 
surgical site infection rates 
Table	2.	Signs	and	symptoms	of	wound	infection	
Classic	signs	of	infection Additional	signs	of	infection
Pyrexia Delayed healing
Pain Dark/discoloured granulation tissue
Oedema Fragile wound tissue
Increased exudate Malodour
Inflammation Cellulitis
Erythema Pocketing at base of wound
Abscess formation
Painful/altered sensation around wound bed
From: Cutting et al, 2005.
Figure 1. 
Critically 
colonized mixed 
disease leg 
ulceration.
Figure 2. Dehiscence of below-knee 
stump due to surgical site infection.
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Table	3.	Wound	dressing	options
Antimicrobial Formulation Examples
Silver Cream, impregnated dressing, ionic 
silver, nanocrystalline silver
Flamazine, Aquacell Ag, Silvercell, 
Acticoat
Honey Impregnated dressing, neat for direct 
application
Algivon, Mesitran, Activon
Polyhexamethylene biguanide (PHMB) Impregnated dressings Kendal AMD, Suprasorb X = + PHMB
Inadine Cream, ointment, spray, impregnated 
dressings, paste
Betadine, Iodoflex, Iodosorb
Chlorhexidine Solution, impregnated dressings Chlorhexitulle
From: Joint Formulary Committee, 2011.
described additional and 
potentially more sensitive 
criteria for identifying wound 
infection including abscess 
formation, cellulitis, 
discharge, delayed healing 
(compared with the normal 
rate of healing for the site and 
condition), discolouration, 
friable granulation tissue that 
bleeds easily, unexpected pain  
and tenderness, pocketing at 
the base of the wound, 
bridging of the epithelium or 
soft tissue, abnormal smell 
and wound breakdown. 
Investigation:	swabs
When there are signs of wound 
infection, a wound swab 
should be taken to identify the 
pathogens involved. It is 
essential that the swab results 
are interpreted in the light of 
the clinical signs and 
symptoms. However, it is 
important to know that there 
is little clinical evidence to 
support the role of wound 
swabs in identifying wound 
infection. The use of a wound 
swab may identify some or all 
of the bacteria within the 
wound, but may not always 
indicate the clinically 
significant species (Wounds 
UK, 2010). 
Despite the limitations of 
wound swabs, they will 
remain part of clinical 
practice until more advanced 
techniques are developed and 
validated (Wounds UK, 2010). 
The identification of the 
infecting microbe helps clarify 
correct management and is 
essential for highlighting 
antibiotic sensitivity.
Identifying	patients	at	
greater	risk	of	infection
Individuals at greater risk of 
wound infections include 
those who are 
immunologically 
compromised, neonates and 
the elderly (White, 2009). 
A patient’s individual 
immune response influences 
the effect of the bacteria 
within the wound. The 
immune response can be 
affected by many factors 
including nutritional status, 
the health of the circulatory 
system, metabolic disorders 
such as diabetes, concurrent 
infections, and medication, 
e.g. steroid therapy.
Patients who smoke are 
also at increased risk of 
developing wound infections 
(Kean, 2010). Increased 
susceptibility to wound 
infection is thought to be due 
to delayed epithelialization as 
a result of reduced white cell 
response and downgraded 
inflammatory response, both 
of which lead to a higher 
bacterial count in the wound 
bed (Kean, 2010).
Kean (2010) also suggested 
that wound dehiscence rates 
may rise in smokers as a 
result of abnormal fibroblast 
morphology, cell adhesion and 
migration, or from a lack of 
collagen being deposited and 
remodelled in the wound bed, 
leading to poor tensile 
strength.
The healthier the patient, 
the more likely that a wound 
will remain harmlessly 
contaminated or colonized 
with microorganisms and the 
less likely infection is to 
develop (Patel, 2007). 
It is important to 
understand the relationship 
between a patient’s immune 
response and the risk of 
infection in order to 
accurately assess individual 
vulnerability to infection, plan 
measures to reduce the risks 
of infection (if possible) and 
provide the patient with the 
appropriate and accurate 
information needed to take 
measures to reduce the risk.
Wound healing in people 
with conditions such as 
diabetes is also impaired. 
Many factors contribute to 
wound healing deficiencies in 
people with diabetes, including 
decreased or impaired growth 
factor production, delayed 
angiogenic response and 
altered macrophage function. 
As a result, people with 
diabetic foot ulceration have a 
high risk of hospitalization, 
lower limb amputation, and 
high mortality rates (Falanga, 
2005) (Figure 3).
An awareness of local 
referral pathways is needed to 
ensure that such patients are 
seen in a timely manner by a 
specialist in the management 
of diabetic foot ulceration.  
It is important that all 
practitioners are aware of 
their limitations and seek 
advice from specialists in 
tissue viability when they  
feel a wound is not 
progressing as expected  
and/or where infection in  
not being controlled. 
 
Management
Correction of the bacterial 
burden reduces inflammation 
in the wound bed and 
therefore promotes healing. 
The use of a topical 
antimicrobial dressing can 
help control bacterial burden. 
Antimicrobial dressings are 
designed to reduce the 
number of pathogens on the 
wound bed to a level that no 
longer impairs wound healing. 
There are many 
antimicrobial dressings on the 
market. These include silver, 
honey, polyhexamethylene 
biguanide (PHMB), inadine 
and chlorhexidine (Table 3). 
Figure 3. Infected diabetic toe 
ulceration.
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All these dressing have 
different physical properties 
and currently there is no clear 
evidence or guidance to 
indicate which product is 
better suited to which type of 
wound or tissue type. 
However, Wounds UK (2010) 
has produced a best practice 
statement on the use of 
topical antiseptic/anti-
microbial agents designed to 
provide guidance for health 
practitioners on when to 
start—and equally 
important—when to stop 
using topical antimicrobial 
agents. 
Wounds UK (2010) 
recommends that in locally 
infected wounds where there 
are no signs of the infection 
spreading, topical antiseptic 
or antimicrobial agents should 
be used. If the signs of 
infection subside and the 
patient shows no signs of 
systemic infection, the 
antiseptic/antimicrobial agent 
should be discontinued. 
In a health service that has 
to account for the cost-
effectiveness of wound 
dressings, it is important to 
observe that, although 
antimicrobial dressings may 
appear to be expensive, they 
may be more cost-effective  
in the long term. In an audit 
of 133 562 individuals, 
McDermott-Scales et al 
(2009) found that 66.7% of 
patients who received wound-
related antibiotics had more 
than one course. Thus the use 
of antimicrobial dressings 
may be both clinically and 
economically effective when 
used appropriately.  
Systemic antibiotics may 
not be the most appropriate 
way to reduce bacterial 
burden in wounds, 
particularly with an increase 
in bacteria resistant to 
antibiotics. Indeed, Howell-
Jones et al (2006) reported 
that general practices 
prescribed more antibiotics 
for patients with chronic 
wounds than for those who 
did not have a chronic 
wound.  
Consideration should be 
given to other methods of 
reducing the bacterial burden, 
including tissue debridement, 
wound cleansing, and 
increased frequency of 
dressing changes. This should 
be done in combination with 
methods to enhance patients’ 
resistance to infection and 
reducing risk factors by 
ensuring that underlying 
vascular disease has been 
addressed, nutritional intake 
is optimized, and oedema is 
controlled, encouraging 
smoking cessation, and 
supporting optimum control 
of blood sugar levels in people 
with diabetes.
Conclusions
The diagnosis of infection  
and critical colonization in 
wounds remains a process of 
recognition and interpretation 
of clinical signs and 
symptoms. Practitioners need 
to have an understanding of 
this process and the 
treatments available, as 
wound infection continues  
to be a challenge and has a 
significant impact in terms  
of quality of life and NHS 
financial burden. Early 
recognition of infection, along 
with prompt and effective 
treatment improves the 
quality of patients’ care.  
It also reduces cost; in the 
current economic climate, 
providing cost-effective care  
is the responsibility of every 
NHS practitioner.
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Key POints
 ➤ Wound infection is a result 
of the dynamic interaction 
that takes place between 
the host and the pathogen 
 ➤ Infection occurs when 
microorganisms grow, 
multiply and invade host 
tissue provoking a systemic 
immunological reaction
 ➤ Wound infection is a 
common surgical 
complication—surgical site 
infections are associated 
with substantial morbidity
 ➤ A topical antimicrobial 
dressing can help control 
bacterial burden by reducing 
the number of pathogens 
on the wound bed
 ➤ Wound infection can delay 
healing and impair patients’ 
quality of life
